Inventor
Raedun CLARKE
Inventor
US
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations22%
C12NMicroorganisms or enzymes22%
A61KPreparations for medical, dental or toiletry purposes15%
C07KPeptides15%
Y02ATechnologies for adaptation to climate change15%
G01NInvestigating or analysing materials by determining their chemical or physical properties11%
PatentTitleYear
12,410,403Methods and compositions for inducing hematopoietic cell differentiation202512,385,012Methods and compositions for inducing hematopoietic cell differentiation202511,634,688Methods and compositions for inducing hematopoietic cell differentiation202311,352,607Genomic engineering of pluripotent cells202211,162,075Methods and compositions for inducing hematopoietic cell differentiation202111,162,076Methods and compositions for inducing hematopoietic cell differentiation2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2025Patents assigned to FATE THERAPEUTICS INC (6)· patent assignee history
2021–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| FATE THERAPEUTICS INC | 6 | 2021–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 6 | 2021–2025 |